Uptake of non-invasive prenatal testing (NIPT) and impact on invasive procedures in a tertiary referral center

Archives of Gynecology and Obstetrics

Volumn 292, Issue 3, 2015, Pages 543-548

  Manegold Brauer, Gwendolin ^a,c   Berg, C ^a,b   Flock A ^a   Ruland A ^a   Gembruch, U ^a   Geipel, A ^a  

^a UNIVERSITY OF BONN   (Germany)

^b UNIVERSITY OF COLOGNE   (Germany)

^c University Medical School   (Switzerland)

Author keywords

Cell free fetal DNA; Fetal aneuploidies; NIPD; NIPT; Non invasive prenatal testing; Prenatal counseling; Trisomy 21

Indexed keywords

ADULT; ALGORITHM; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC TEST; FEMALE; FETUS ECHOGRAPHY; FIRST TRIMESTER PREGNANCY; HIGH RISK PATIENT; HIGH RISK POPULATION; HIGH RISK PREGNANCY; HUMAN; INTERMEDIATE RISK POPULATION; INVASIVE PROCEDURE; LOW RISK POPULATION; MAJOR CLINICAL STUDY; NON INVASIVE PRENATAL TESTING; PREGNANCY TEST; PRENATAL SCREENING; REASSURANCE; RETROSPECTIVE STUDY; TERTIARY CARE CENTER; DNA SEQUENCE; DOWN SYNDROME; MATERNAL AGE; MATERNAL SERUM SCREENING TEST; PREGNANCY; PRENATAL CARE; PRENATAL DIAGNOSIS; PROCEDURES; RISK FACTOR;

ADULT; ALGORITHMS; DOWN SYNDROME; FEMALE; HUMANS; MATERNAL AGE; MATERNAL SERUM SCREENING TESTS; PREGNANCY; PREGNANCY TRIMESTER, FIRST; PRENATAL CARE; PRENATAL DIAGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SEQUENCE ANALYSIS, DNA; TERTIARY CARE CENTERS;

EID: 84938747364     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-015-3674-5     Document Type: Article

References (36)

1. Bianchi DW, Wilkins-Haug L (2014) Integration of noninvasive DNA testing for aneuploidy into prenatal care: what has happened since the rubber met the road? Clin Chem 60(1):78–87
2. Chiu RWK, Lo YMD (2013) Clinical applications of maternal plasma fetal DNA analysis: translating the fruits of 15 years of research. Clin Chem Lab Med 51(1):197–204
3. Sehnert AJ, Rava RP, Bianchi DW (2013) A new era in noninvasive prenatal testing. N Engl J Med 369(22):2164–2165
4. Bianchi DW, Oepkes D, Ghidini A (2014) Current controversies in prenatal diagnosis 1: should noninvasive DNA testing be the standard screening test for Down syndrome in all pregnant women? Prenat Diagn 34(1):6–11
5. Kagan KO, Eiben B, Kozlowski P (2014) Kombiniertes Ersttrimesterscreening und zellfreie fetale DNA: “Next Generation Screening”. Ultraschall Med 35(3):229–236
6. Syngelaki A, Pergament E, Homfray T, Akolekar R, Nicolaides KH (2014) Replacing the combined test by cell-free DNA testing in screening for trisomies 21, 18 and 13: impact on the diagnosis of other chromosomal abnormalities. Fetal Diagn Ther 35(3):174–184
7. Nicolaides KH, Wright D, Poon LC, Syngelaki A, Gil MM (2013) First-trimester contingent screening for trisomy 21 by biomarkers and maternal blood cell-free DNA testing. Ultrasound Obstet Gynecol 42(1):41–50
8. Devers P, Cronister A, Ormond K, Facio F, Brasington C, Flodman P (2013) Noninvasive prenatal testing/noninvasive prenatal diagnosis: the position of the national society of genetic counselors. J Genet Couns. 22(3):291–295
9. Benn P, Borell A, Chiu R, Cuckle H, Dugoff L, Faas B et al (2013) Position statement from the Aneuploidy Screening Committee on behalf of the Board of the International Society for Prenatal Diagnosis. Prenat Diagn 33(7):622–629
10. Committee Opinion No. 545 (2012) Noninvasive prenatal testing for fetal aneuploidy. Obstet Gynecol 120(6):1532–1534
11. Kagan KO, Etchegaray A, Zhou Y, Wright D, Nicolaides KH (2009) Prospective validation of first-trimester combined screening for trisomy 21. Ultrasound Obstet Gynecol 34(1):14–18
12. Ekelund CK, Jørgensen FS, Petersen OB, Sundberg K, Tabor A (2008) Impact of a new national screening policy for Down’s syndrome in Denmark: population based cohort study. BMJ 337:a2547
13. Wapner R, Thom E, Simpson JL, Pergament E, Silver R, Filkins K et al (2003) First-trimester screening for trisomies 21 and 18. N Engl J Med 349(15):1405–1413
14. Hagen A, Entezami M, Gasiorek-Wiens A, Albig M, Becker R, Knoll U et al (2011) The impact of first trimester screening and early fetal anomaly scan on invasive testing rates in women with advanced maternal age. Ultraschall Med 32(3):302–306
15. Haddow JE, Palomaki GE, Knight GJ, Cunningham GC, Lustig LS, Boyd PA (1994) Reducing the need for amniocentesis in women 35 years of age or older with serum markers for screening. N Engl J Med 330(16):1114–1118
16. Wray AM, Ghidini A, Alvis C, Hodor J, Landy HJ, Poggi SH (2005) The impact of first-trimester screening on AMA patients’ uptake of invasive testing. Prenat Diagn 25(5):350–353
17. Geipel A, Daiss T, Katalinic A, Germer U, Kohl T, Krapp M et al (2007) Changing attitudes towards non-invasive aneuploidy screening at advanced maternal age in a German tertiary care center. Ultraschall Med 28(1):67–70
18. Lüthgens K, Merz E, Hackelöer BJ, Thode C, Eiben B, Kagan KO (2013) Comparison of three first trimester screening algorithms for trisomy 21 with and without adjustment for maternal characteristics. Ultraschall Med 34(2):151–156
19. Nicolaides KH (2011) Screening for fetal aneuploidies at 11 to 13 weeks. Prenat Diagn 31(1):7–15
20. Kagan KO, Wright D, Spencer K, Molina FS, Nicolaides KH (2008) First-trimester screening for trisomy 21 by free beta-human chorionic gonadotropin and pregnancy-associated plasma protein-A: impact of maternal and pregnancy characteristics. Ultrasound Obstet Gynecol 31(5):493–502
21. Chiu R, Akolekar R, Zheng YWL, Leung T, Sun H, Chan K et al (2011) Non-invasive prenatal assessment of trisomy 21 by multiplexed maternal plasma DNA sequencing: large scale validity study. BMJ 432:c7401
22. Ehrich M, Deciu C, Zwiefelhofer T, Tynan JA, Cagasan L, Tim R et al (2011) Noninvasive detection of fetal trisomy 21 by sequencing of DNA in maternal blood: a study in a clinical setting. Am J Obstet Gynecol 204(205):e1–e11
23. Sparks AB, Struble CA, Wang ET, Song K, Oliphant A (2012) Non-invasive prenatal detection and selective analysis of cell-free DNA obtained from maternal blood: evaluation for trisomy 21 and trisomy 18. Am J Obstet Gynecol 206(322):e1–e5
24. Palomaki GE, Kloza EM, Lambert-Messerlian GM, Haddow JE, Neveux LM, Ehrich M et al (2011) DNA sequencing of maternal plasma to detect Down syndrome: an international clinical validation study. Genet Med Off J Am Coll Med Genet. 13:913–920
25. Chen E, Chiu RWK, Sun H, Akolekar R, Chan K, Leung T et al (2011) Noninvasive prenatal diagnosis of fetal trisomy 18 and trisomy 13 by maternal plasma DNA sequencing. PLoS ONE 6(7):e21791
26. Bianchi DW, Platt LD, Goldberg JD, Abuhamad AZ, Sehnert AJ, Rava RP (2012) Genome-wide fetal aneuploidy detection by maternal plasma DNA sequencing. Obstet Gynecol 119:1–13
27. Norton ME, Brar H, Weiss J, Karimi A, Laurent LC, Caughey AB et al (2012) Non-invasive chromosomal evaluation (NICE) study: results of a multicenter prospective cohort study for detection of fetal trisomy 21 and trisomy 18. Am J Obstet Gynecol 207:1–8
28. Guex N, Iseli C, Syngelaki A, Deluen C, Pescia G, Nicolaides KH et al (2013) A robust second-generation genome-wide test for fetal aneuploidy based on shotgun sequencing cell-free DNA in maternal blood. Prenat Diagn 33(7):707–710
29. Gil MM, Akolekar R, Quezada MS, Bregant B, Nicolaides KH (2014) Analysis of cell-free DNA in maternal blood in screening for aneuploidies: meta-analysis. Fetal Diagn Ther 35(3):156–173
30. Wellesley D, Dolk H, Boyd PA, Greenlees R, Haeusler M, Nelen V et al (2012) Rare chromosome abnormalities, prevalence and prenatal diagnosis rates from population-based congenital anomaly registers in Europe. Eur J Hum Genet 20(5):521–526
31. Chetty S, Garabedian MJ, Norton ME (2013) Uptake of noninvasive prenatal testing (NIPT) in women following positive aneuploidy screening. Prenat Diagn 33(6):542–546
32. Friel LA, Czerwinski JL, Singletary CN (2014) The impact of noninvasive prenatal testing on the practice of maternal-fetal medicine. Am J Perinatol 31(9):759–764
33. Kagan KO, Avgidou K, Molina FS, Gajewska K, Nicolaides KH (2006) Relation between increased fetal nuchal translucency thickness and chromosomal defects. Obstet Gynecol 107(1):6–10
34. Manegold-Brauer G, Kang Bellin A, Hahn S, De Geyter C, Buechel J, Hoesli I et al (2014) A new era in prenatal care: non-invasive prenatal testing (NIPT) in Switzerland. Swiss Med Wkly. 144:w13915
35. Platt LD, Janicki MB, Prosen T, Goldberg JD, Adashek J, Figueroa R et al (2014) Impact of noninvasive prenatal testing in regionally dispersed medical centers in the United States. Am J Obstet Gynecol 211(4):368.e1–368.e7
36. Gil MM, Quezada MS, Bregant B, Ferraro M, Nicolaides KH (2013) Implementation of maternal blood cell-free DNA testing in early screening for aneuploidies. Ultrasound Obstet Gynecol 42(1):34–40